Garg Amit, Balthasar Joseph P
Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, Buffalo, NY 14260, USA.
J Pharmacokinet Pharmacodyn. 2007 Oct;34(5):687-709. doi: 10.1007/s10928-007-9065-1. Epub 2007 Jul 18.
Although it is known that FcRn, the neonatal Fc-receptor, functions to protect immune gamma globulin (IgG) from elimination, the influence of FcRn on the tissue distribution of IgG has not been quantified. In the present work, a physiologically-based pharmacokinetic (PBPK) model has been developed to characterize and predict IgG disposition in plasma and in tissues. The model includes nine major compartments, connected in an anatomical manner, to represent tissues known to play a significant role in IgG disposition. Each tissue compartment was subdivided into vascular, endosomal and interstitial spaces. IgG transport between the blood and interstitial compartments may proceed by convection through paracellular pores in the vascular endothelium, or via FcRn-mediated transcytosis across vascular endosomal cells. The model was utilized to characterize plasma concentration-time data for 7E3, a monoclonal antiplatelet IgG1 antibody, in control and FcRn-knockout (KO) mice. These data showed that high dose intravenous immunoglobulin (IVIG), 1g/kg, increased 7E3 clearance in control mice from 5.2 +/- 0.3 to 14.4 +/- 1.4 ml/d/kg; however, IVIG failed to increase the clearance of 7E3 in KO mice (72.5 +/- 4.0 vs. 61.0 +/- 3.6 ml/d/kg). Based on model fitting to the 7E3 plasma concentration data, simulations were conducted to predict tissue concentrations of IgG in control and in KO mice, and the predictions were then tested by assessing 7E3 tissue distribution in KO mice and control mice. 7E3 was radiolabeled with Iodine-125 using chloramine T method, and (125)I-7E3 IgG was administered at a dose of 8 mg/kg to control and KO mice. At various time points, sub-groups of 3 mice were sacrificed, blood and tissue samples were collected, and radioactivity assessed by gamma counting. PBPK model performance was assessed by comparing model predictions with the observed data. The model accurately predicted 7E3 tissue concentrations, with mean predicted vs. observed AUC ratios of 1.04 +/- 0.2 and 0.86 +/- 0.3 in control and FcRn-KO mice. The PBPK model, which incorporates the influence of FcRn on IgG clearance and disposition, was found to provide accurate predictions of IgG tissue kinetics in control and FcRn-knockout mice.
尽管已知新生儿Fc受体FcRn具有保护免疫球蛋白(IgG)不被清除的功能,但FcRn对IgG组织分布的影响尚未得到量化。在本研究中,我们建立了一个基于生理学的药代动力学(PBPK)模型,以表征和预测IgG在血浆和组织中的处置情况。该模型包括九个主要隔室,以解剖学方式连接,代表已知在IgG处置中起重要作用的组织。每个组织隔室又细分为血管、内体和间质空间。血液和间质隔室之间的IgG转运可能通过血管内皮细胞旁细胞孔的对流进行,或者通过FcRn介导的跨细胞转运穿过血管内体细胞。该模型用于表征7E3(一种单克隆抗血小板IgG1抗体)在对照小鼠和FcRn基因敲除(KO)小鼠中的血浆浓度-时间数据。这些数据表明,高剂量静脉注射免疫球蛋白(IVIG),1g/kg,可使对照小鼠中7E3的清除率从5.2±0.3增加到14.4±1.4 ml/d/kg;然而,IVIG未能增加KO小鼠中7E3的清除率(72.5±4.0对61.0±3.6 ml/d/kg)。基于对7E3血浆浓度数据的模型拟合,进行了模拟以预测对照小鼠和KO小鼠中IgG的组织浓度,然后通过评估KO小鼠和对照小鼠中7E3的组织分布来检验这些预测。使用氯胺T法用碘-125对7E3进行放射性标记,并以8 mg/kg的剂量将(125)I-7E3 IgG给予对照小鼠和KO小鼠。在不同时间点,处死3只小鼠的亚组,收集血液和组织样本,并通过γ计数评估放射性。通过将模型预测与观察数据进行比较来评估PBPK模型性能。该模型准确预测了7E3的组织浓度,在对照小鼠和FcRn-KO小鼠中,预测的平均AUC与观察到的AUC比值分别为1.04±0.2和0.86±0.3。发现纳入FcRn对IgG清除和处置影响的PBPK模型能够准确预测对照小鼠和FcRn基因敲除小鼠中IgG的组织动力学。